Neuroleptic malignant syndrome is a rare but serious adverse effect of
antipsychotic medication. The author describes three new cases and reviews
50 others published in the past 5 years. Demographic and clinical features,
diagnosis, treatment, outcome, and pathophysiology are critically reviewed,
and a new set of diagnostic criteria, incorporating physical signs and
routine laboratory tests, is proposed.